Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders.
Alkermes is seeking an experienced Program Manager to support the development and execution of the ALKS 2680 program, a novel treatment for narcolepsy and idiopathic hypersomnia. The ideal candidate will have previous experience with late-stage development and registration submission preparation and support.
Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders.
Alstom